Correlation Between Rakovina Therapeutics and Marvel Discovery

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rakovina Therapeutics and Marvel Discovery at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rakovina Therapeutics and Marvel Discovery into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rakovina Therapeutics and Marvel Discovery Corp, you can compare the effects of market volatilities on Rakovina Therapeutics and Marvel Discovery and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rakovina Therapeutics with a short position of Marvel Discovery. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rakovina Therapeutics and Marvel Discovery.

Diversification Opportunities for Rakovina Therapeutics and Marvel Discovery

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Rakovina and Marvel is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Rakovina Therapeutics and Marvel Discovery Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marvel Discovery Corp and Rakovina Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rakovina Therapeutics are associated (or correlated) with Marvel Discovery. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marvel Discovery Corp has no effect on the direction of Rakovina Therapeutics i.e., Rakovina Therapeutics and Marvel Discovery go up and down completely randomly.

Pair Corralation between Rakovina Therapeutics and Marvel Discovery

Assuming the 90 days horizon Rakovina Therapeutics is expected to generate 0.55 times more return on investment than Marvel Discovery. However, Rakovina Therapeutics is 1.81 times less risky than Marvel Discovery. It trades about 0.03 of its potential returns per unit of risk. Marvel Discovery Corp is currently generating about -0.03 per unit of risk. If you would invest  8.00  in Rakovina Therapeutics on August 31, 2024 and sell it today you would earn a total of  0.00  from holding Rakovina Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Rakovina Therapeutics  vs.  Marvel Discovery Corp

 Performance 
       Timeline  
Rakovina Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rakovina Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Rakovina Therapeutics is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Marvel Discovery Corp 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Marvel Discovery Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Marvel Discovery showed solid returns over the last few months and may actually be approaching a breakup point.

Rakovina Therapeutics and Marvel Discovery Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rakovina Therapeutics and Marvel Discovery

The main advantage of trading using opposite Rakovina Therapeutics and Marvel Discovery positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rakovina Therapeutics position performs unexpectedly, Marvel Discovery can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marvel Discovery will offset losses from the drop in Marvel Discovery's long position.
The idea behind Rakovina Therapeutics and Marvel Discovery Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios